Infectious Diseases

COVID-19 vaccines, blood clots and anticoagulation therapy: insights from Dr Ng Heng Joo

COVID-19 vaccines, blood clots and anticoagulation therapy: insights from Dr Ng Heng Joo

Vaccine-induced thrombotic thrombocytopenia (VITT), a condition characterised by blood clots resulting from COVID-19 vaccinations, is a rare but serious concern in the fight against COVID-19. This Q&A with Dr Ng Heng Joo, Head & Senior Consultant in the Department of Haematology at Singapore General Hospital, explores the pathophysiology, diagnosis of VITT and clinical management of […]

COVID-19 vaccines, blood clots and anticoagulation therapy: insights from Dr Ng Heng Joo Read More »

How coagulation diagnostics support COVID-19 vaccination and patient management

How coagulation diagnostics support COVID-19 vaccination and patient management

Infection with COVID-19 has been associated with thrombosis, or blood clots, involving the veins and arteries. The risk of blood clots is highest for individuals admitted to hospital with COVID-19 infection, occurring in about 5% of people admitted to a regular hospital ward and up to 20% for those in the intensive care unit (ICU),

How coagulation diagnostics support COVID-19 vaccination and patient management Read More »

HCV elimination in Northern Pakistan: Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands

HCV elimination in Northern Pakistan: Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands

This article is part of a series on hepatitis C (HCV) elimination in Pakistan and other high-risk countries around the world. Forthcoming articles in this series will cover the Pakistani provinces of Sindh and Punjab. Scroll to the bottom of the article for the full list. Khyber Pakhtunkhwa province, or KPK, is situated in the

HCV elimination in Northern Pakistan: Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands Read More »

COVID passes, ‘self-sovereign identity’ and the future of medical data

COVID passes, ‘self-sovereign identity’ and the future of medical data

Key to returning the world to normal in the COVID era is to have an agreed means of confirming that those who wish to move around have tested negative, been vaccinated, or fulfill whatever criteria authorities decide allow for safe passage. While there are dozens of solutions being explored and piloted, debate still revolves about

COVID passes, ‘self-sovereign identity’ and the future of medical data Read More »

CEO viewpoint: Prof Hans Widjaya on digital health and COVID-19 in Indonesia

CEO viewpoint: Prof Hans Widjaya on digital health and COVID-19 in Indonesia

Founded in 2012, National Hospital in Surabaya is a leading private healthcare facility in Indonesia that has brought many new healthcare technologies to the country, from electronic health records to saliva-based PCR tests. Located on the eastern side of the island of Java, its achievements offer a framework for how other facilities in Indonesia can

CEO viewpoint: Prof Hans Widjaya on digital health and COVID-19 in Indonesia Read More »

Liver disease in Asia Pacific: insights from Prof Pierce Chow

Liver disease in Asia Pacific: Q&A with Prof Pierce Chow

In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical management of common liver diseases like HBV, HCV, fatty liver and HCC; and the critical role of diagnostics in ensuring early detection and effective treatment. [00:09] – Prof Chow’s

Liver disease in Asia Pacific: insights from Prof Pierce Chow Read More »

Border control policy and COVID diagnostics in Asia: insights from Dr Swee Kheng Khor

Border control policy & covid diagnostics - Dr Khor Swee Kheng

Even with the widespread rollout of vaccines, negative COVID test results remain a requirement for crossing borders in most countries. In this Q&A, global health expert Dr Swee Kheng (“SK”) Khor discusses the current state of border control policy in the Asia Pacific region and the critical role of clinical laboratories in safe travel ecosystems.

Border control policy and COVID diagnostics in Asia: insights from Dr Swee Kheng Khor Read More »

LEADx virtual roundtable addresses India’s COVID surge

LEADx virtual roundtable 2021

In recent months India’s COVID-19 situation has worsened significantly, eclipsing other countries with the second-highest number of cases and, at the time this article was written, the third-highest number of recorded deaths on the planet. At the recent LEADx virtual roundtable discussion moderated by Dr Anil Handoo, Senior Lab Director at BLK Super Speciality Hospital, on 30

LEADx virtual roundtable addresses India’s COVID surge Read More »

Scroll to Top